Transcriptome Analyses of Myometrium from Fibroid Patients Reveals Phenotypic Differences Compared to Non-Diseased Myometrium

Int J Mol Sci. 2021 Mar 31;22(7):3618. doi: 10.3390/ijms22073618.

Abstract

Uterine fibroid tissues are often compared to their matched myometrium in an effort to understand their pathophysiology, but it is not clear whether the myometria of uterine fibroid patients represent truly non-disease control tissues. We analyzed the transcriptomes of myometrial samples from non-fibroid patients (M) and compared them with fibroid (F) and matched myometrial (MF) samples to determine whether there is a phenotypic difference between fibroid and non-fibroid myometria. Multidimensional scaling plots revealed that M samples clustered separately from both MF and F samples. A total of 1169 differentially expressed genes (DEGs) (false discovery rate < 0.05) were observed in the MF comparison with M. Overrepresented Gene Ontology terms showed a high concordance of upregulated gene sets in MF compared to M, particularly extracellular matrix and structure organization. Gene set enrichment analyses showed that the leading-edge genes from the TGFβ signaling and inflammatory response gene sets were significantly enriched in MF. Overall comparison of the three tissues by three-dimensional principal component analyses showed that M, MF, and F samples clustered separately from each other and that a total of 732 DEGs from F vs. M were not found in the F vs. MF, which are likely understudied in the pathogenesis of uterine fibroids and could be key genes for future investigation. These results suggest that the transcriptome of fibroid-associated myometrium is different from that of non-diseased myometrium and that fibroid studies should consider using both matched myometrium and non-diseased myometrium as controls.

Keywords: CCND1; SERPINE1; field effect; myometrium; uterine fibroids.

MeSH terms

  • Adult
  • Female
  • Gene Expression Profiling / methods
  • Genetic Association Studies / methods
  • Genotype
  • Humans
  • Leiomyoma / genetics*
  • Leiomyoma / pathology
  • Middle Aged
  • Myometrium / metabolism
  • Myometrium / pathology*
  • Phenotype
  • Principal Component Analysis / methods
  • Transcriptome / genetics
  • Uterine Neoplasms / genetics
  • Uterine Neoplasms / pathology
  • Uterus / metabolism
  • Uterus / pathology*